These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17225195)

  • 1. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines.
    Zehnder BS; Schaer BA; Jeker U; Cron TA; Osswald S
    Swiss Med Wkly; 2006 Dec; 136(47-48):757-60. PubMed ID: 17225195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
    Haeusler KG; Gerth A; Limbourg T; Tebbe U; Oeff M; Wegscheider K; Treszl A; Ravens U; Meinertz T; Kirchhof P; Breithardt G; Steinbeck G; Nabauer M;
    BMC Neurol; 2015 Aug; 15():129. PubMed ID: 26242880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation anticoagulation care in a large urban family medicine practice.
    Valentinis A; Ivers N; Bhatia S; Meshkat N; Leblanc K; Ha A; Morra D
    Can Fam Physician; 2014 Mar; 60(3):e173-9. PubMed ID: 24627401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention.
    Sur NB; Saini V; Torres LF; Atchaneeyasakul K; Malik AM; Yavagal DR; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105599. PubMed ID: 33545519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
    McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
    Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice.
    McBride D; Brüggenjürgen B; Roll S; Willich SN
    J Thromb Thrombolysis; 2007 Aug; 24(1):65-72. PubMed ID: 17260164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Goudevenos J; Lekakis J;
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):545-549. PubMed ID: 26825445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study.
    Vanbeselaere V; Truyers C; Elli S; Buntinx F; De Witte H; Degryse J; Henrard S; Vaes B
    BMC Cardiovasc Disord; 2016 Mar; 16():61. PubMed ID: 27021333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?
    Willems R; Exner DV
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():9-16. PubMed ID: 14739734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center.
    Bradley BC; Perdue KS; Tisdel KA; Gilligan DM
    Am J Cardiol; 2000 Mar; 85(5):568-72. PubMed ID: 11078269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.